Imperial College London

DrBethanDavies

Faculty of MedicineSchool of Public Health

Clinical Senior Lecturer in Epidemiology
 
 
 
//

Contact

 

+44 (0)20 7594 8994bethan.davies06

 
 
//

Location

 

Medical SchoolSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@techreport{Davies:2016:10.2900/667703,
author = {Davies, B and Ward, H},
doi = {10.2900/667703},
publisher = {European Centre for Disease Prevention and Control},
title = {Guidance on chlamydia control in Europe 2015},
url = {http://dx.doi.org/10.2900/667703},
year = {2016}
}

RIS format (EndNote, RefMan)

TY  - RPRT
AB - Executive summaryThis evidence-based guidance updates the 2009 ECDC Chlamydia control in Europe guidance [5]. It was developed by a technical expert group using evidence gathered by the Chlamydia control in Europe programme of work, which ECDC commissioned in 2011 and presented in three accompanying technical reports in 2014 and 2015. The work included a critical review and update of the scientific evidence on the epidemiology and natural history of chlamydia and the clinical and cost-effectiveness of screening programmes, an update of information aboutchlamydia prevention and control activities in EU/EEA Member States, and a review of the impact of the 2009 ECDC chlamydia control guidance. In 2014, an expert consultation provided in-depth information about the use of the 2009 guidance within countries and made suggestions for the revision of the guidance.The aim of this guidance is to support Member States to develop, implement or improve national or local strategies for chlamydia control. This guidance sets out the current evidence base behind the proposed options, highlights key gaps in knowledge, and suggests effective options for national chlamydia control strategies. It is directedprimarily at policy advisors but should be useful for programme managers and experts in sexual health, especially those at the European or national levels.The evidence-based options presented here should be interpreted and applied according to clinical, epidemiological, healthcare and resource environments: there is marked variation in current chlamydia controlstrategies across EU/EEA Member States which reflects differences in available resources, health priorities and uncertainties in the evidence-base for chlamydia control interventions. The evidence base for primary prevention activities is still deficient but expert opinion is that it is prudent to offer these interventions to all at-risk individuals.Diagnosing and treating cases of chlamydia can improve the health of the affect
AU - Davies,B
AU - Ward,H
DO - 10.2900/667703
PB - European Centre for Disease Prevention and Control
PY - 2016///
TI - Guidance on chlamydia control in Europe 2015
UR - http://dx.doi.org/10.2900/667703
UR - http://ecdc.europa.eu/en/publications/publications/chlamydia-control-europe-guidance.pdf
ER -